Revolution Medicines · 11 hours ago
Intern, Information Sciences, Business Analyst (CRM)
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies. In this role, you will assist in managing the global CRM ecosystem, gathering requirements, supporting the CRM roadmap, participating in user acceptance testing, and creating training materials for users.
Health CareLife ScienceMedical
Responsibilities
Assist in interviewing stakeholders across Commercial Development and Clinical & Medical Affairs to document business needs and translate them into technical user stories
Help maintain the strategic CRM roadmap, ensuring project timelines are up to date
Participate in testing new system features to ensure they work perfectly before they are released to our field teams
Create training materials, “how-to” guides, and communications to help our users adopt new CRM capabilities
Qualification
Required
Currently pursuing a Bachelor's degree in Information Systems, Computer Science, Business Administration, or related field
You enjoy solving puzzles and figuring out how different systems or data points connect
Strong written and verbal skills; you can explain a technical idea to a non-technical person
Preferred
Interest in the biotech/pharmaceutical industry
Continuous improvement mindset – you're always looking for a better way to do things
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase